Xuemei Ye

475 total citations
40 papers, 366 citations indexed

About

Xuemei Ye is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Xuemei Ye has authored 40 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Xuemei Ye's work include Metal and Thin Film Mechanics (5 papers), Thyroid Cancer Diagnosis and Treatment (5 papers) and Diamond and Carbon-based Materials Research (3 papers). Xuemei Ye is often cited by papers focused on Metal and Thin Film Mechanics (5 papers), Thyroid Cancer Diagnosis and Treatment (5 papers) and Diamond and Carbon-based Materials Research (3 papers). Xuemei Ye collaborates with scholars based in China, United States and Switzerland. Xuemei Ye's co-authors include Jing Hu, Jiqiang Wu, Heqing Yi, Linfa Li, Ting Ye, Han Liu, Yongli Zhu, Yating Chai, Lili Zhong and Lijun Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and European Journal of Pharmacology.

In The Last Decade

Xuemei Ye

38 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuemei Ye China 12 89 82 76 57 55 40 366
Keiko Watanabe Japan 13 60 0.7× 100 1.2× 31 0.4× 36 0.6× 24 0.4× 67 471
Changle Zhang China 12 56 0.6× 83 1.0× 115 1.5× 11 0.2× 153 2.8× 41 422
Mengyue Chen China 16 33 0.4× 147 1.8× 59 0.8× 16 0.3× 64 1.2× 64 652
Krzysztof Lis Poland 9 76 0.9× 53 0.6× 40 0.5× 5 0.1× 81 1.5× 47 434
Jeonghan Kim South Korea 13 14 0.2× 159 1.9× 26 0.3× 19 0.3× 86 1.6× 23 434
Yu Liao China 12 11 0.1× 75 0.9× 51 0.7× 84 1.5× 96 1.7× 29 459
Ankush Bansal India 12 122 1.4× 115 1.4× 15 0.2× 13 0.2× 149 2.7× 44 482
Panpan Zhang China 13 27 0.3× 153 1.9× 89 1.2× 9 0.2× 209 3.8× 41 666
Qinghui Hu China 13 55 0.6× 81 1.0× 54 0.7× 6 0.1× 32 0.6× 35 617
Yu-Hsin Wang Taiwan 11 84 0.9× 31 0.4× 42 0.6× 46 0.8× 14 0.3× 44 497

Countries citing papers authored by Xuemei Ye

Since Specialization
Citations

This map shows the geographic impact of Xuemei Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuemei Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuemei Ye more than expected).

Fields of papers citing papers by Xuemei Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuemei Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuemei Ye. The network helps show where Xuemei Ye may publish in the future.

Co-authorship network of co-authors of Xuemei Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Xuemei Ye. A scholar is included among the top collaborators of Xuemei Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuemei Ye. Xuemei Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Youhua, Jianqiang Li, Jiangfeng Wang, et al.. (2024). Neoadjuvant chemoradiotherapy (nCRT) combined with sequential tislelizumab for resectable esophageal squamous cell carcinoma (ESCC): Preliminary results of a single-arm, open-label phase Ib trial (CRIS).. Journal of Clinical Oncology. 42(16_suppl). e16116–e16116. 2 indexed citations
3.
Ye, Xuemei, et al.. (2024). Effects of vitamin D supplementation on diabetic foot ulcer healing: a meta-analysis. Postgraduate Medical Journal. 101(1192). 100–107. 3 indexed citations
4.
Wang, Jiahui, Xuping Yang, Xuemei Ye, et al.. (2024). Exosomes in malignant pleural effusions: Sources and applications. Chinese Medical Journal. 137(11). 1381–1383. 1 indexed citations
5.
Li, Yanyan, et al.. (2024). Stigma and self-esteem in facial burn patients: A correlation study. Burns. 50(5). 1341–1348. 8 indexed citations
6.
Liu, Yanan, et al.. (2022). A high throughput method for Monitoring of Sorafenib, regorafenib, cabozantinib and their metabolites with UPLC-MS/MS in rat plasma. Frontiers in Pharmacology. 13. 955263–955263. 6 indexed citations
7.
Wang, Yingying, et al.. (2021). UPLC‐MS/MS Determination of Linezolid and Heme in Plasma of Infected Patients and Correlation Analysis. BioMed Research International. 2021(1). 6679076–6679076. 3 indexed citations
8.
Ye, Xuemei, et al.. (2020). Lnc NEAT1/miR-29b-3p/Sp1 form a positive feedback loop and modulate bortezomib resistance in human multiple myeloma cells. European Journal of Pharmacology. 891. 173752–173752. 14 indexed citations
9.
Yi, Heqing, Xuemei Ye, Ting Ye, et al.. (2017). Inhibition of the AKT/mTOR Pathway Augments the Anticancer Effects of Sorafenib in Thyroid Cancer. Cancer Biotherapy and Radiopharmaceuticals. 32(5). 176–183. 22 indexed citations
10.
Xiao, Zhousheng, et al.. (2017). The Efficacy of Rituximab Combined with <sup>131</sup>I for Ophthalmic Outcomes of Graves' Ophthalmopathy Patients. Pharmacology. 99(3-4). 144–152. 13 indexed citations
11.
Li, Linfa, Lifang Yao, Heqing Yi, et al.. (2015). Combined use of radioiodine therapy and radiofrequency ablation in treating postsurgical thyroid remnant of differentiated thyroid carcinoma. Journal of Cancer Research and Therapeutics. 11(8). 244–244. 11 indexed citations
12.
Yi, Heqing, et al.. (2014). Autophagy: A potential target for thyroid cancer therapy (Review). Molecular and Clinical Oncology. 2(5). 661–665. 14 indexed citations
13.
Shields, CarolL, Xuemei Ye, & Swathi Kaliki. (2014). Rapid regression of choroidal metastasis from lung cancer using erlotinib (Tarceva). Oman Journal of Ophthalmology. 7(2). 75–75. 10 indexed citations
14.
Ye, Xuemei, Rajesh Guntupalli, Ramji S. Lakshmanan, Bryan A. Chin, & Jing Hu. (2014). Comparative study of thermal stability of magnetostrictive biosensor between two kinds of biorecognition elements. Materials Science and Engineering C. 41. 78–82. 5 indexed citations
15.
Ye, Xuemei, Jiqiang Wu, Yongli Zhu, & Jing Hu. (2014). A study of the effect of propane addition on plasma nitrocarburizing for AISI 1045 steel. Vacuum. 110. 74–77. 22 indexed citations
16.
Sui, Dexin, Xinjing Xu, Xuemei Ye, et al.. (2014). Protein Interaction Module–assisted Function X (PIMAX) Approach to Producing Challenging Proteins Including Hyperphosphorylated Tau and Active CDK5/p25 Kinase Complex. Molecular & Cellular Proteomics. 14(1). 251–262. 19 indexed citations
17.
Ye, Xuemei, et al.. (2013). A Study on an Energy-saving and High-efficient Pack Boriding Technology for Tool and Die Steels. Physics Procedia. 50. 76–81. 4 indexed citations
18.
Cheruvelil, Kendra Spence & Xuemei Ye. (2012). Do College Introductory Biology Courses Increase Student Ecological Literacy. The journal of college science teaching. 42(2). 50–56. 1 indexed citations
20.
Yang, Weng-Lang, et al.. (2003). Development of cross-resistance between heat and cisplatin or hydroxyurea treatments in fadu squamous carcinoma cells. Journal of Surgical Research. 111(1). 143–151. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026